DigiPath

(OTC: DIGP)
Healthcare  |  Diagnostics & Research
0.06 0.0 0.0%
Stock Price | April 7, 2020, 3:50 p.m.
3 Followers
Bid: 0.03
Ask: 0.1099
Prev. Close: 0.058088
52 Week Low: 0.036
52 Week High: 0.0776
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

DigiPath Inc is a US-based company engaged in providing pharmaceutical-grade analysis and testing cannabis education and training and brings unbiased cannabis news coverage to the cannabis industry. It screens medicinal cannabis for potentially harmful contaminants, including solvents, pesticides, mold and yeast, heavy metals such as mercury, arsenic, lead, and cadmium, biological toxins, such as aflatoxin, ricin, botulinum toxin and microbial contaminants including E. coli, salmonella, Aspergillus, and fungus. It also tests cannabis for its quality, potency, and cannabinoid and terpene profiles, which determine the suitability of specific cannabis strains for the treatment of specific ailments.

Read more Read less

Recently Viewed Tickers

Premium Cannabis Stocks Review - Pre-Market Edition 01/23/18

27 Comments
2 years ago

Premium Cannabis Stocks Review - Weekend Edition 01/22/18

73 Comments
2 years ago

Premium Focus List Review - 01/14/18

4 Comments
2 years ago

Premium Cannabis Stocks Review - Weekend Edition 01/16/18

20 Comments
2 years ago

Premium Cannabis Stocks Review - Pre-Market Edition 01/11/18

25 Comments
2 years ago

Premium Cannabis Stocks Review - Weekend Edition 01/08/18

42 Comments
2 years ago

Premium Weekly Review 01/05/18

46 Comments
2 years ago

Premium Mid-Week Chat - 01/03/18

32 Comments
2 years ago

Premium Cannabis Stocks Review - Weekend Edition 01/02/18

49 Comments
2 years ago

Premium Weekly Review 12/29/17

2 Comments
2 years ago